Coronavirus Header Image

America’s biopharmaceutical companies are committed to developing solutions to help diagnose and treat those with COVID-19, a disease caused by a novel strain of coronavirus.


LATEST ARTICLES


RELATED ARTICLES

Advancing Mental Health Solutions Amid COVID-19

As we make progress in the fight against COVID-19, experts are warning of another pending public health crisis: mental health. 

Immunization Awareness Month Thumbnail

The Incredible Power of Immunization

In 1796, the trajectory of our relationship with disease changed permanently when Edward Jenner invented the first vaccine.

Gloved hands using pipette and test tubes.

The Innovation Ecosystem Fuels Breakthroughs

Biopharmaceutical research companies are uniquely positioned to take the necessary risks to further advance research into safe and effective treatments for patients.

5 Recent Developments Advancing Vaccines

As communities continue to grapple with the impact of COVID-19, vaccines have once again come to the forefront as a critical health care tool.

World IP Day image

How Intellectual Property Protections Spur Innovation

Strong IP protections are critical to safeguarding innovation within the biopharmaceutical industry. 

Infectious Disease Progress Thumbnail

Progress Against Infectious Diseases: Where Do We Stand?

Over the years, treatments for infectious diseases have grown steadily more complex, and today, our ability to respond to diseases like COVID-19 is radically different than it would have been even a few decades ago.

Coronavirus Thumbnail

Fighting Back Against the Coronavirus

As people across the globe continue to be impacted by COVID-19, the disease caused by a new strain of coronavirus, biopharmaceutical companies have rapidly taken action to research and develop potential new medicines, while partnering with public health leaders worldwide, to combat this global public health emergency.